Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Characteristics of Participants Who Completed Enrollment Study Visit, by Chronic Hepatitis C Virus Status Characteristic | Participants With HCV (n = 58) | Participants Without HCV (n = 58) | P Value: Vitamin D supplement use | 11 (19.0) | 17 (29.3) | .193
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We conducted a cross-sectional study among 58 participants with chronic HCV and 58 participants without HCV.
Source: Abstract.
Interested patients were screened for potential eligibility via self-reported responses.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines
Cross-sectional study · Open Forum Infectious Diseases · 2025
Original publication title
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Hepatitis C virus (HCV) infection is associated with reduced bone mineral density (BMD) and increased fracture risk. The structural underpinnings for skeletal fragility with HCV and contributions of inflammatory cytokines remain unknown. We used high-resolution peripheral quantitative computed tomography (HR-pQCT) to compare skeletal parameters by chronic HCV.
Source: BackgroundAbstract: What methods does the paper describe?
We conducted a cross-sectional study among 58 participants with chronic HCV and 58 participants without HCV. Volumetric BMD and cortical dimensions of the radius and tibia were determined by HR-pQCT; visceral fat area and appendicular lean mass were assessed by whole body dual-energy x-ray absorptiometry; serum levels of tumor necrosis factor α (TNF-α), interleukin 6, and interleukin 18 were measured. Multivariable linear regression was used to estimate group differences in bone measurements and cytokines.
Source: MethodsAbstract: Results
Participants with chronic HCV had lower radius trabecular volumetric BMD (−24.2 mg hydroxyapatite [HA]/cm3) and lower tibia trabecular volumetric BMD (−20.5 mg HA/cm3), cortical area (−20.9 mm2), and cortical thickness (−0.47 mm) than participants without HCV (all P < .05), independent of age, sex, visceral fat area, appendicular lean mass, and smoking. Mean log TNF-α was higher with chronic HCV (+0.1-log pg/mL; P < .001), but no differences in mean log interleukin 6 or interleukin 18 were observed.
Higher log TNF-α was associated with lower radius trabecular volumetric BMD (−99.7 mg HA/cm3), lower tibia cortical volumetric BMD (−91.6 mg HA/cm3), and higher tibia cortical porosity (+1.39%) by HR-pQCT (all P < .05).
Source: ResultsAbstract: Conclusions
Patients with chronic HCV had decreased trabecular volumetric BMD and cortical dimensions and higher TNF-α than individuals without infection, suggesting that HCV-associated inflammation might contribute to bone deficits.
Source: ConclusionsAuthors’ abstract
Abstract
Background
Hepatitis C virus (HCV) infection is associated with reduced bone mineral density (BMD) and increased fracture risk. The structural underpinnings for skeletal fragility with HCV and contributions of inflammatory cytokines remain unknown. We used high-resolution peripheral quantitative computed tomography (HR-pQCT) to compare skeletal parameters by chronic HCV.
Methods
We conducted a cross-sectional study among 58 participants with chronic HCV and 58 participants without HCV. Volumetric BMD and cortical dimensions of the radius and tibia were determined by HR-pQCT; visceral fat area and appendicular lean mass were assessed by whole body dual-energy x-ray absorptiometry; serum levels of tumor necrosis factor α (TNF-α), interleukin 6, and interleukin 18 were measured. Multivariable linear regression was used to estimate group differences in bone measurements and cytokines.
Results
Participants with chronic HCV had lower radius trabecular volumetric BMD (−24.2 mg hydroxyapatite [HA]/cm3) and lower tibia trabecular volumetric BMD (−20.5 mg HA/cm3), cortical area (−20.9 mm2), and cortical thickness (−0.47 mm) than participants without HCV (all P < .05), independent of age, sex, visceral fat area, appendicular lean mass, and smoking. Mean log TNF-α was higher with chronic HCV (+0.1-log pg/mL; P < .001), but no differences in mean log interleukin 6 or interleukin 18 were observed.
Higher log TNF-α was associated with lower radius trabecular volumetric BMD (−99.7 mg HA/cm3), lower tibia cortical volumetric BMD (−91.6 mg HA/cm3), and higher tibia cortical porosity (+1.39%) by HR-pQCT (all P < .05).
Conclusions
Patients with chronic HCV had decreased trabecular volumetric BMD and cortical dimensions and higher TNF-α than individuals without infection, suggesting that HCV-associated inflammation might contribute to bone deficits.
Publication and source details
Original title: Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines
Erica J Weinstein; Dean M Carbonari; Craig W Newcomb; Jessie Torgersen; Shanae M Smith; Katherine L Brecker; X Sherry Liu; Jay R Kostman; Stacey Trooskin; Rebecca A Hubbard; Joshua F Baker; Babette S Zemel; Mary B Leonard; Vincent Lo Re III
Open Forum Infectious Diseases · 2025
Correspondence: Vincent Lo Re III, MD, MSCE, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, 836 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104-6021 (vincentl@pennmedicine.upenn.edu); Erica J. Weinstein, MD, MSCE, Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 3801 Filbert St, Suite 103, Philadelphia, PA 19104 (erica.weinstein@pennmedicine.upenn.edu).Potential conflicts of interest. All authors: No reported conflicts.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T05:29:15.984449+00:00
DOI: 10.1093/ofid/ofaf102 · PMC12039487